InflaRx NV (IFRX)
1.55
-0.04
(-2.52%)
USD |
NASDAQ |
Oct 13, 16:00
1.55
0.00 (0.00%)
After-Hours: 20:00
InflaRx Total Return Price : 1.55 for Oct. 13, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| October 13, 2026 | 1.55 |
| October 12, 2026 | 1.59 |
| October 09, 2026 | 1.60 |
| October 08, 2026 | 1.53 |
| October 07, 2026 | 1.56 |
| October 06, 2026 | 1.58 |
| October 05, 2026 | 1.68 |
| October 02, 2026 | 1.72 |
| October 01, 2026 | 1.71 |
| September 30, 2026 | 1.80 |
| September 29, 2026 | 1.85 |
| September 28, 2026 | 1.82 |
| September 25, 2026 | 1.89 |
| September 24, 2026 | 1.93 |
| September 23, 2026 | 1.96 |
| September 22, 2026 | 2.08 |
| September 21, 2026 | 2.12 |
| September 18, 2026 | 2.09 |
| September 17, 2026 | 2.06 |
| September 16, 2026 | 2.04 |
| September 15, 2026 | 2.02 |
| September 14, 2026 | 2.12 |
| September 11, 2026 | 2.09 |
| September 10, 2026 | 2.05 |
| September 09, 2026 | 2.09 |
| Date | Value |
|---|---|
| September 08, 2026 | 2.17 |
| September 04, 2026 | 2.22 |
| September 03, 2026 | 2.23 |
| September 02, 2026 | 2.29 |
| September 01, 2026 | 2.16 |
| August 31, 2026 | 2.13 |
| August 28, 2026 | 2.23 |
| August 27, 2026 | 2.27 |
| August 26, 2026 | 2.42 |
| August 25, 2026 | 2.46 |
| August 24, 2026 | 2.05 |
| August 21, 2026 | 2.10 |
| August 20, 2026 | 2.02 |
| August 19, 2026 | 2.12 |
| August 18, 2026 | 2.18 |
| August 17, 2026 | 2.07 |
| August 14, 2026 | 2.04 |
| August 13, 2026 | 2.01 |
| August 12, 2026 | 2.01 |
| August 11, 2026 | 2.00 |
| August 10, 2026 | 1.96 |
| August 07, 2026 | 1.84 |
| August 06, 2026 | 1.72 |
| August 05, 2026 | 1.77 |
| August 04, 2026 | 1.78 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| MediGene AG | 0.10 |
| BioNTech SE | 89.01 |
| Immatics NV | 6.83 |
| Arrowhead Pharmaceuticals, Inc. | 58.13 |
| Oncolytics Biotech, Inc. | 0.49 |